Skip to main content Accessibility help

A Model to Predict Central-Line–Associated Bloodstream Infection Among Patients With Peripherally Inserted Central Catheters: The MPC Score

  • Erica Herc (a1) (a2), Payal Patel (a1) (a2) (a3), Laraine L. Washer (a1) (a2) (a3), Anna Conlon (a4), Scott A. Flanders (a4) (a5) and Vineet Chopra (a4) (a5)...



Peripherally inserted central catheters (PICCs) are associated with central-line–associated bloodstream infections (CLABSIs). However, no tools to predict risk of PICC-CLABSI have been developed.


To operationalize or prioritize CLABSI risk factors when making decisions regarding the use of PICCs using a risk model to estimate an individual’s risk of PICC-CLABSI prior to device placement.


Using data from the Michigan Hospital Medicine Safety consortium, patients that experienced PICC-CLABSI between January 2013 and October 2016 were identified. A Cox proportional hazards model with robust sandwich standard error estimates was then used to identify factors associated with PICC-CLABSI. Based on regression coefficients, points were assigned to each predictor and summed for each patient to create the Michigan PICC-CLABSI (MPC) score. The predictive performance of the score was assessed using time-dependent area-under-the-curve (AUC) values.


Of 23,088 patients that received PICCs during the study period, 249 patients (1.1%) developed a CLABSI. Significant risk factors associated with PICC-CLABSI included hematological cancer (3 points), CLABSI within 3 months of PICC insertion (2 points), multilumen PICC (2 points), solid cancers with ongoing chemotherapy (2 points), receipt of total parenteral nutrition (TPN) through the PICC (1 point), and presence of another central venous catheter (CVC) at the time of PICC placement (1 point). The MPC score was significantly associated with risk of CLABSI (P<.0001). For every point increase, the hazard ratio of CLABSI increased by 1.63 (95% confidence interval, 1.56–1.71). The area under the receiver-operating-characteristics curve was 0.67 to 0.77 for PICC dwell times of 6 to 40 days, which indicates good model calibration.


The MPC score offers a novel way to inform decisions regarding PICC use, surveillance of high-risk cohorts, and utility of blood cultures when PICC-CLABSI is suspected. Future studies validating the score are necessary.

Infect Control Hosp Epidemiol 2017;38:1155–1166


Corresponding author

Address correspondence to Vineet Chopra, MD, MSc, 2800 Plymouth Road, Building 16, #432W, Ann Arbor, MI 48109 (


Hide All
1. Chopra, V, Anand, S, Krein, SL, Chenoweth, C, Saint, S. Bloodstream infection, venous thrombosis, and peripherally inserted central catheters: reappraising the evidence. Am J Med 2012;125:733741.
2. Climo, M, Diekema, D, Warren, DK, et al. Prevalence of the use of central venous access devices within and outside of the intensive care unit: results of a survey among hospitals in the prevention epicenter program of the Centers for Disease Control and Prevention. Infect Control Hosp Epidemiol 2003;24:942945.
3. Hoshal, VL Jr. Total intravenous nutrition with peripherally inserted silicone elastomer central venous catheters. Arch Surg 1975;110:644646.
4. Chopra, V, Kuhn, L, Ratz, D, et al. Vascular access specialist training, experience, and practice in the United States: results from the national PICC1 survey. J Infus Nurs 2017;40:1525.
5. Chopra, V, Kuhn, L, Ratz, D, Flanders, SA, Krein, SL. Vascular nursing experience, practice knowledge, and beliefs: results from the Michigan PICC1 survey. J Hosp Med 2016;11:269275.
6. Chopra, V, Smith, S, Swaminathan, L, et al. Variations in peripherally inserted central catheter use and outcomes in Michigan hospitals. JAMA Intern Med 2016;176:548551.
7. Alexandrou, E, Spencer, TR, Frost, SA, Mifflin, N, Davidson, PM, Hillman, KM. Central venous catheter placement by advanced practice nurses demonstrates low procedural complication and infection rates—a report from 13 years of service. Crit Care Med 2014;42:536543.
8. Lamperti, M, Bodenham, AR, Pittiruti, M, et al. International evidence-based recommendations on ultrasound-guided vascular access. Intensive Care Med 2012;38:11051117.
9. Ajenjo, MC, Morley, JC, Russo, AJ, et al. Peripherally inserted central venous catheter-associated bloodstream infections in hospitalized adult patients. Infect Control Hosp Epidemiol 2011;32:125130.
10. Aw, A, Carrier, M, Koczerginski, J, McDiarmid, S, Tay, J. Incidence and predictive factors of symptomatic thrombosis related to peripherally inserted central catheters in chemotherapy patients. Thrombo Res 2012;130:323326.
11. Grau, D, Clarivet, B, Lotthe, A, Bommart, S, Parer, S. Complications with peripherally inserted central catheters (PICCs) used in hospitalized patients and outpatients: a prospective cohort study. Antimicrob Resist Infect Control 2017;6:18.
12. Warren, DK, Quadir, WW, Hollenbeak, CS, Elward, AM, Cox, MJ, Fraser, VJ. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital. Crit Care Med 2006;34:20842089.
13. Singh, S, Kumar, RK, Sundaram, KR, Kanjilal, B, Nair, P. Improving outcomes and reducing costs by modular training in infection control in a resource-limited setting. Int J Qual Health Care 2012;24:641648.
14. Safdar, N, Maki, DG. Risk of catheter-related bloodstream infection with peripherally inserted central venous catheters used in hospitalized patients. Chest 2005;128:489495.
15. Pongruangporn, M, Ajenjo, MC, Russo, AJ, et al. Patient- and device-specific risk factors for peripherally inserted central venous catheter-related bloodstream infections. Infect Control Hosp Epidemiol 2013;34:184189.
16. Chopra, V, Montoya, A, Joshi, D, et al. Peripherally inserted central catheter use in skilled nursing facilities: a pilot mixed methods study. J Am Geriatrics Society 2015. doi: 10.1111/jgs.13600.
17. Cornillon, J, Martignoles, JA, Tavernier-Tardy, E, et al. Prospective evaluation of systematic use of peripherally inserted central catheters (PICC lines) for the home care after allogeneic hematopoietic stem cells transplantation. Support Care Cancer 2017.
18. Chopra, V, Govindan, S, Kuhn, L, et al. Do clinicians know which of their patients have central venous catheters? A multicenter observational study. Ann Intern Med 2014;161:562567.
19. Baxi, SM, Shuman, EK, Scipione, CA, et al. Impact of postplacement adjustment of peripherally inserted central catheters on the risk of bloodstream infection and venous thrombus formation. Infect Control Hosp Epidemiol 2013;34:785792.
20. Greene, MT, Spyropoulos, AC, Chopra, V, et al. Validation of risk assessment models of venous thromboembolism in hospitalized medical patients. Am J Med 2016;129:1001e10091001 e1018.
21. Greene, MT, Flanders, SA, Woller, SC, Bernstein, SJ, Chopra, V. The association between PICC use and venous thromboembolism in upper and lower extremities. Am J Med 2015;128:986993 e981.
22. Grant, PJ, Greene, MT, Chopra, V, Bernstein, SJ, Hofer, TP, Flanders, SA. Assessing the Caprini score for risk assessment of venous thromboembolism in hospitalized medical patients. Am J Med 2016;129:528535.
23. Mimoz, O, Lucet, JC, Kerforne, T, et al. Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial. Lancet 2015;386:20692077.
24. Hopke, PK, Liu, C, Rubin, DB. Multiple imputation for multivariate data with missing and below-threshold measurements: time-series concentrations of pollutants in the Arctic. Biometrics 2001;57:2233.
25. Rubin, DB, Schenker, N. Multiple imputation in health-care databases: an overview and some applications. Stat Med 1991;10:585598.
26. Fine, MJ, Auble, TE, Yealy, DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243250.
27. Halbesma, N, Jansen, DF, Heymans, MW, et al. Development and validation of a general population renal risk score. Clin J Am Soc Nephrol 2011;6:17311738.
28. Wasson, JH, Sox, HC, Neff, RK, Goldman, L. Clinical prediction rules. Applications and methodological standards. N Engl J Med 1985;313:793799.
29. Heagerty, PJ, Zheng, Y. Survival model predictive accuracy and ROC curves. Biometrics 2005;61:92105.
30. Moons, KG, Kengne, AP, Woodward, M, et al. Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker. Heart 2012;98:683690.
31. Heagerty, PJ, Lumley, T, Pepe, MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 2000;56:337344.
32. Miller, ME, Langefeld, CD, Tierney, WM, Hui, SL, McDonald, CJ. Validation of probabilistic predictions. Med Decis Making 1993;13:4958.
33. Harrell, FE. Regression Modeling Strategies. New York: Springer-Verlag; 2001.
34. Shaffer, JP. Multiple hypothesis testing. Annu Rev Psychol 1995;46:561584.
35. Chopra, V, O’Horo, JC, Rogers, MA, Maki, DG, Safdar, N. The risk of bloodstream infection associated with peripherally inserted central catheters compared with central venous catheters in adults: a systematic review and meta-analysis. Infect Control Hosp Epidemiol 2013;34:908918.
36. O’Brien, J, Paquet, F, Lindsay, R, Valenti, D. Insertion of PICCs with minimum number of lumens reduces complications and costs. J Am Coll Radiol 2013;10:864868.
37. Bozaan, DA, Tupps, M, Brancaccio, A, et al. LESS LUMENS = LESS RISK [abstract]. J Hosp Med 2017;12(Suppl 2). Accessed July 28, 2017.
38. Smith, SN, Moureau, N, Vaughn, VM, et al. Patterns and predictors of peripherally inserted central catheter occlusion: the 3P-O study. J Vasc Interv Radiol 2017.
39. Wylie, MC, Graham, DA, Potter-Bynoe, G, et al. Risk factors for central line-associated bloodstream infection in pediatric intensive care units. Infect Control Hosp Epidemiol 2010;31:10491056.
40. Hakko, E, Guvenc, S, Karaman, I, Cakmak, A, Erdem, T, Cakmakci, M. Long-term sustainability of zero central-line associated bloodstream infections is possible with high compliance with care bundle elements. East Mediterr Health J 2015;21:293298.
41. Harnage, SA. A PICC team ends CRBSIs. RN 2008;71:3436, 38–39.
42. Chopra, V, Flanders, SA, Saint, S, et al. The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC): results from a multispecialty panel using the RAND/UCLA appropriateness method. Ann Intern Med 2015;163:S1S40.
43. Keren, R, Shah, SS, Srivastava, R, et al. Comparative effectiveness of intravenous vs oral antibiotics for postdischarge treatment of acute osteomyelitis in children. JAMA Pediatr 2015;169:120128.
44. Shah, SS, Srivastava, R, Wu, S, et al. Intravenous versus oral antibiotics for postdischarge treatment of complicated pneumonia. Pediatrics 2016;138.
45. Shrestha, NK, Bhaskaran, A, Scalera, NM, Schmitt, SK, Rehm, SJ, Gordon, SM. Contribution of infectious disease consultation toward the care of inpatients being considered for community-based parenteral anti-infective therapy. J Hosp Med 2012;7:365369.
46. Sharma, R, Loomis, W, Brown, RB. Impact of mandatory inpatient infectious disease consultation on outpatient parenteral antibiotic therapy. Am J Med Sci 2005;330:6064.
47. Kramer, RD, Rogers, MA, Conte, M, Mann, J, Saint, S, Chopra, V. Are antimicrobial peripherally inserted central catheters associated with reduction in central line-associated bloodstream infection? A systematic review and meta-analysis. Am J Infect Control 2017;45:108114.

A Model to Predict Central-Line–Associated Bloodstream Infection Among Patients With Peripherally Inserted Central Catheters: The MPC Score

  • Erica Herc (a1) (a2), Payal Patel (a1) (a2) (a3), Laraine L. Washer (a1) (a2) (a3), Anna Conlon (a4), Scott A. Flanders (a4) (a5) and Vineet Chopra (a4) (a5)...


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed